Dutch-Arthritis Impact Measurement Scales 2

Abstract

The Dutch-Arthritis Impact Measurement Scales 2 (Dutch-AIMS2) is a disease-specific patient-reported outcome measure (PROM) designed to assess health-related quality of life (HRQoL) and multi-dimensional functional status in individuals diagnosed with rheumatoid arthritis, osteoarthritis, and related chronic rheumatic diseases. Adapted and psychometrically validated in the Netherlands by Robert P. Riemsma and colleagues in 1994 from the revised American version (AIMS2) developed by Robert F. Meenan and John H. Mason (1991), the instrument captures patient experiences over a one-month recall period. The core measurement model comprises 57 items categorized into 12 primary subscales: Mobility Level, Walking and Bending, Hand and Finger Function, Arm Function, Self-Care, Household Tasks, Social Activity, Support from Family and Friends, Arthritis Pain, Work, Level of Tension, and Mood. These 12 subscales coalesce into five higher-order health domains: Physical Functioning, Affect/Psychological Status, Symptoms, Social Interaction, and Role/Work. Items are rated on a five-point Likert scale, and raw scores for each subscale are normalized to a standardized scale ranging from 0 to 10, where 0 designates optimal health status (no limitation or impairment) and 10 designates severe limitation or poor health. Psychometric evaluations of the Dutch-AIMS2 demonstrate excellent internal consistency reliability, with Cronbach’s alpha coefficients typically ranging from 0.70 to 0.91 across subscales, high test-retest reliability (intraclass correlation coefficients ranging between 0.78 and 0.94), and robust convergent validity against reference standards such as the Health Assessment Questionnaire (HAQ), the Disease Activity Score (DAS28), and clinical metrics of joint inflammation. The instrument exhibits proven responsiveness to pharmacological and non-pharmacological clinical interventions, establishing its enduring relevance in clinical rheumatology, rehabilitative research, and longitudinal health services evaluations.

Keywords

Dutch-AIMS2, Arthritis Impact Measurement Scales, Rheumatoid Arthritis, Osteoarthritis, Health-Related Quality of Life, Functional Status, Psychometrics, Patient-Reported Outcome Measures, Physical Disability, Chronic Pain Assessment

Authors

The conceptual and methodological architecture of the original Arthritis Impact Measurement Scales was pioneered in the United States by Robert F. Meenan, MD, MPH, MBA, and John H. Mason, PhD, based at the Boston University School of Medicine and the Multipurpose Arthritis Center. Dr. Meenan, an internationally recognized rheumatologist and health services researcher, served as Dean of the Boston University School of Public Health and led foundational efforts to operationalize multidimensional health status profiling in chronic musculoskeletal disease throughout the late 1970s and 1980s. Following the 1980 release of the original 45-item AIMS, Meenan and Mason expanded and refined the battery into the 78-item AIMS2 in 1991 to broaden clinical sensitivity and capture upper-extremity nuances, social networks, and patient satisfaction.

The linguistic translation, cross-cultural adaptation, and comprehensive psychometric validation of the Dutch-language version were executed in the Netherlands by Robert P. Riemsma, PhD, in close collaboration with Johannes J. Rasker, MD, PhD, Gerjo A. M. Kok, PhD, and H. J. Bernelot Moens, MD, PhD. Dr. Riemsma conducted this landmark validation work within the Department of Communication Studies and Department of Rheumatology at the University of Twente (Enschede, The Netherlands) and the Medisch Spectrum Twente hospital. His research established normative baselines, test-retest stability parameters, and structural validity metrics for the Dutch-AIMS2 across multiple cohorts of patients with rheumatoid arthritis and generalized osteoarthritis. Correspondence regarding the historical development and regional adaptation was primarily managed through the University of Twente’s health psychology and rheumatology research consortium.

Purpose

The primary purpose of the Dutch-AIMS2 is to systematically quantify the multidimensional impact of chronic rheumatic and arthritic conditions on an individual’s functional capacity, psychological equilibrium, pain presentation, and social engagement. Chronic inflammatory and degenerative joint diseases—predominantly rheumatoid arthritis and osteoarthritis—are characterized by persistent joint destruction, chronic systemic inflammation, debilitating fatigue, and functional limitations. Historically, clinical rheumatology relied almost exclusively on biomedical markers such as erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), radiographic joint space narrowing, and physician-performed swollen and tender joint counts. While these variables provide critical insights into pathophysiological disease activity, they demonstrate weak-to-moderate correlations with the patient’s day-to-day lived experiences, affective distress, vocational impairment, and overall health-related quality of life.

The Dutch-AIMS2 bridges this translational gap by functioning as a comprehensive, disease-specific outcome measure. It is explicitly designed for both clinical research trials and routine observational clinical practice. In clinical trials, the Dutch-AIMS2 serves as a responsive secondary or co-primary endpoint evaluating the efficacy of disease-modifying antirheumatic drugs (DMARDs), biologic therapies, targeted synthetic therapies, orthopedic surgical interventions, and comprehensive physical therapy regimens. In routine longitudinal clinical practice, it enables clinicians to monitor chronic disease trajectories, identify hidden affective distress or social isolation, tailor multi-disciplinary rehabilitative interventions, and facilitate shared medical decision-making between rheumatologists and patients.

From a health policy and health economics perspective, the scale provides standardized health profile data that can be tracked over years. Because the instrument covers both upper and lower extremity functioning, personal self-care, domestic productivity, vocational engagement, pain magnitude, and emotional well-being (tension and mood), it circumvents the ceiling and floor effects often encountered in unidimensional disability scales that focus exclusively on basic activities of daily living.

Psychological Construct

The Dutch-AIMS2 operationalizes health-related quality of life (HRQoL) as a complex, hierarchical, multidimensional construct. Within this framework, health is not merely the absence of joint tenderness or anatomical deformity, but a multifaceted state encompassing physical competence, psychological resilience, symptom severity, role performance, and social integration. The core measurement architecture comprises 57 items organized into 12 discrete subscales:

1. Mobility Level (Items 1–5)

This subscale assesses gross ambulatory independence, room-to-room confinement, and community mobility. Items capture the frequency with which an individual can drive a car, use public transit, walk freely around their neighborhood, or conversely, find themselves confined to a bed, chair, or home setting due to musculoskeletal limitations.

2. Walking and Bending (Items 6–10)

Measuring lower extremity biomechanical function, dynamic balance, and axial flexibility, this dimension evaluates the capacity to walk one or several blocks without assistive devices or personal support, climb single or multiple flights of stairs, and stoop or bend down from the waist to retrieve dropped objects.

3. Hand and Finger Function (Items 11–15)

Reflecting fine motor coordination, bilateral manual dexterity, and pinch strength, this subscale evaluates critical micro-tasks such as writing with a pen or pencil, fastening small clothing buttons, turning keys in door locks, tying shoelaces, and opening vacuum-sealed food containers.

4. Arm Function (Items 16–20)

Focusing on proximal upper-extremity strength and active range of motion across the glenohumeral, acromioclavicular, and elbow joints, items assess wiping one’s mouth with a napkin, dressing by pulling pullovers over the head, combing or brushing hair, scratching the lower back, and reaching overhead to retrieve items from elevated shelves.

5. Self-Care (Items 21–24)

This dimension examines fundamental activities of daily living (ADLs) necessary for personal autonomy, including independently washing and drying the entire body, safely stepping into and out of bathtubs or shower stalls, executing toilet transfers, and dressing independently without assistance.

6. Household Tasks (Items 25–28)

Covering instrumental activities of daily living (IADLs), this subscale assesses the functional capacity to perform domestic maintenance, including grocery shopping, preparing balanced meals, executing light chores (dusting, dishwashing), and managing strenuous household responsibilities (vacuuming, floor scrubbing).

7. Social Activity (Items 29–33)

Addressing interpersonal integration and external community engagement, items monitor how frequently the patient connects socially with family or friends, engages in telephone communications, attends meetings of clubs or community organizations, ventures out for leisure entertainment, and receives social visits in their home environment.

8. Support from Family and Friends (Items 34–37)

This subscale operationalizes perceived social support, empathetic bonding, and instrumental assistance. It gauges whether the individual feels validated, cared for, and emotionally supported, feels free to discuss chronic illness struggles, and experiences satisfaction with the practical assistance rendered by their primary social network.

9. Arthritis Pain (Items 38–42)

Quantifying sensory-discriminative symptom burden, this dimension assesses the frequency of severe joint pain, concurrent polyarticular involvement, pain interference with essential daily activities, the duration of prolonged morning stiffness (>60 minutes), and the baseline severity of typical joint pain experienced over the prior month.

10. Work (Items 43–47)

Evaluating occupational disability and economic productivity, this subscale determines the degree to which joint pathology forces reductions in working hours, alters vocational roles, creates absenteeism, or causes subjective workplace struggle in full-time or part-time employment.

11. Level of Tension (Items 48–52)

This affective subscale assesses generalized somatic and cognitive anxiety, inner agitation, autonomic arousal, emotional volatility, and perceived stress coping capacity over the previous 30-day window.

12. Mood (Items 53–57)

Targeting psychological distress and depressive symptomology, this dimension measures states of despair, dysphoria, hedonic deficit (inability to enjoy previously cherished activities), hopelessness regarding disease course, and comparative optimism.

Theoretical Framework

The theoretical underpinnings of the Dutch-AIMS2 are deeply anchored in the biopsychosocial model of chronic illness proposed by George L. Engel, combined with the World Health Organization’s foundational International Classification of Impairments, Disabilities, and Handicaps (ICIDH) and its evolution into the International Classification of Functioning, Disability and Health (ICF). Engel asserted that chronic disease cannot be understood or treated strictly as a biological lesion; rather, it reflects dynamic, reciprocal interactions among cellular pathology, cognitive appraisal, emotional regulation, and sociocultural environments.

Within the ICIDH/ICF conceptual architecture, the manifestations of rheumatic diseases are parsed into three interconnected levels:

• Impairment (Body Functions and Structures): Structural joint erosion, synovial inflammation, capsular fibrosis, and nociceptive signaling (captured by the Arthritis Pain and stiffness items).
• Activity Limitation (Disabilities): Difficulties executing specific physical tasks, fine-motor actions, mobility routines, or self-care regimens (captured across the Mobility, Walking/Bending, Hand/Finger, Arm, Self-Care, and Household subscales).
• Participation Restriction (Handicap / Role Impairment): Inability to fully participate in societal, vocational, leisure, and relational domains (captured within the Social Activity, Support, and Work subscales).

Furthermore, the inclusion of the Level of Tension and Mood subscales directly aligns with Richard Lazarus and Susan Folkman’s Transactional Model of Stress and Coping. Chronic, unremitting joint pain and progressive physical disability serve as chronic environmental and somatic stressors. An individual’s cognitive appraisal of their functional losses (e.g., catastrophizing vs. perceived self-efficacy) dictates whether the emotional reaction tilts toward chronic anxiety, perceived helplessness, depressive resignation, or adaptive psychological adjustment. By embedding psychological and social support domains alongside structural biomechanical indices, the Dutch-AIMS2 provides an integrated behavioral-medicine assessment model that mirrors modern clinical health psychology.

Validity

The psychometric validity of the Dutch-AIMS2 has been extensively examined across diverse Dutch clinical cohorts, verifying construct, criterion, convergent, discriminant, and longitudinal predictive validity.

Construct and Convergent Validity

In the primary Dutch validation studies conducted by Riemsma et al. (1994, 1996) involving hundreds of patients with rheumatoid arthritis, construct validity was established by comparing Dutch-AIMS2 subscales against established gold-standard instruments. The Dutch-AIMS2 physical subscales demonstrated strong, statistically significant convergent correlations with the Dutch version of the Health Assessment Questionnaire (HAQ), yielding Pearson correlation coefficients ranging from r = 0.65 to r = 0.82 (p < 0.001). Specifically, the Walking and Bending, Self-Care, and Household Tasks subscales exhibited the highest convergence with HAQ disability scores.

The Arthritis Pain subscale correlates robustly with 100-mm Visual Analogue Scales (VAS) measuring joint pain (r = 0.72 to 0.78), while the psychological subscales (Level of Tension and Mood) demonstrate strong convergent correlations (r = 0.68 to 0.76) with established mental health measures, including the Mental Health subscale of the Medical Outcomes Study Short-Form 36 (SF-36) and the Hospital Anxiety and Depression Scale (HADS).

Discriminant Validity

Discriminant validity has been consistently confirmed through the Dutch-AIMS2’s ability to differentiate between clinical cohorts with differing anatomical disease patterns and systemic severity. In comparative trials between rheumatoid arthritis (a systemic, symmetric polyarthritis) and localized osteoarthritis (e.g., unilateral hip or knee degeneration), the Dutch-AIMS2 clearly differentiates profiles: patients with rheumatoid arthritis score significantly higher on Hand and Finger Function, Arm Function, and Level of Tension, whereas patients with end-stage lower-extremity osteoarthritis present isolated, elevated scores on Walking and Bending, while retaining normal upper extremity scores.

Moreover, the physical subscales demonstrate weak, non-significant correlations with unrelated constructs such as general intellectual functioning or non-somatized social attitudes (r < 0.20), substantiating divergent validity.

Predictive Validity and Responsiveness

Longitudinal studies demonstrate that the Dutch-AIMS2 is sensitive to clinically meaningful change over time (responsiveness). In randomized controlled trials evaluating pharmacotherapies (such as TNF-alpha inhibitors) and interdisciplinary rheumatology rehabilitation programs, effect sizes (Cohen’s d) and standardized response means (SRM) on the Arthritis Pain, Mobility, and Household Tasks subscales exceeded 0.60 to 0.85 following therapeutic stabilization, confirming the instrument’s utility for longitudinal clinical tracking.

Reliability

Extensive psychometric investigations substantiate the high reliability of the Dutch-AIMS2 across patient populations presenting with mild, moderate, and severe rheumatologic diagnoses.

Internal Consistency

Internal consistency reliability, evaluated using Cronbach’s alpha (α), has been demonstrated to meet or exceed standard psychometric benchmarks (≥ 0.70 for research comparisons; ≥ 0.80 for individual diagnostic evaluations) across virtually all subscales:

• Mobility Level: α = 0.74 – 0.82
• Walking and Bending: α = 0.85 – 0.90
• Hand and Finger Function: α = 0.78 – 0.86
• Arm Function: α = 0.80 – 0.87
• Self-Care: α = 0.72 – 0.79
• Household Tasks: α = 0.84 – 0.89
• Social Activity: α = 0.68 – 0.74
• Support from Family and Friends: α = 0.76 – 0.83
• Arthritis Pain: α = 0.82 – 0.88
• Work: α = 0.81 – 0.87
• Level of Tension: α = 0.83 – 0.88
• Mood: α = 0.86 – 0.91

Across the aggregated higher-order domains (e.g., Upper Extremity, Lower Extremity, Affect), Cronbach’s alpha values frequently range from 0.88 to 0.94.

Test-Retest Reliability

Temporal stability has been verified through test-retest administration over stable intervals ranging from 7 to 14 days among outpatients with medically stable rheumatoid arthritis. Intraclass correlation coefficients (ICC) and Pearson correlation coefficients consistently demonstrate high reproducibility:

• Physical Function subscales: ICC = 0.84 to 0.94
• Pain subscale: ICC = 0.78 to 0.85
• Psychological subscales: ICC = 0.79 to 0.88
• Social subscales: ICC = 0.75 to 0.82

Standard Error of Measurement (SEM) and Smallest Detectable Change (SDC) calculations indicate that an absolute change of approximately 1.0 to 1.5 points on any 0–10 normalized subscale reflects authentic clinical variation rather than measurement noise at the 95% confidence interval.

Factor Analysis

Both exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) have established the structural dimensionality of the Dutch-AIMS2. When Meenan and Mason developed the original AIMS2, they confirmed that the primary subscales aggregate into five major second-order dimensions. During the Dutch adaptation and validation, Riemsma et al. (1996) examined whether this five-component model retained structural invariance in a European healthcare context.

First-Order Factor Structure

Principal components analysis with varimax and oblimin rotations on the 57 individual items confirms the presence of 12 distinct first-order factors that cleanly align with the theoretical subscales. Individual item factor loadings on their designated latent factors are robust, virtually all exceeding λ = 0.55, with primary cross-loadings remaining low (< 0.30). A minor exception observed in the Dutch sample involved some overlap between general mobility (e.g., leaving the home) and lower-extremity walking items, reflecting the strong physical interdependence of these daily activities.

Second-Order (Higher-Order) Factor Structure

Factor analysis of the 12 subscale scores routinely yields a clear five-factor solution accounting for over 68% of the total variance:

1. Physical Functioning Factor: High loadings from Mobility Level (0.76), Walking and Bending (0.84), Hand and Finger Function (0.71), Arm Function (0.75), Self-Care (0.80), and Household Tasks (0.82).
2. Affect / Psychological Factor: Marked by heavy loadings from Level of Tension (0.87) and Mood (0.89).
3. Symptom / Pain Factor: Dominated by Arthritis Pain (0.88), with secondary moderate loadings from Morning Stiffness and physical interference items.
4. Social Interaction Factor: Composed of Social Activity (0.81) and Support from Family and Friends (0.78).
5. Work / Role Functioning Factor: Defined primarily by the Work subscale items (0.85) in economically active cohorts.

Confirmatory factor analytic (CFA) fit indices across Dutch patient datasets confirm satisfactory model fit for this five-dimensional second-order structure: Comparative Fit Index (CFI) > 0.92, Tucker-Lewis Index (TLI) > 0.91, and Root Mean Square Error of Approximation (RMSEA) ≤ 0.062 (90% CI: 0.055–0.069). These empirical results substantiate that the Dutch-AIMS2 successfully captures both discrete functional capabilities and overarching health domains.

Instrument / Measurement Tool

• Instrument Name: Dutch-Arthritis Impact Measurement Scales 2 (Dutch-AIMS2)
• Original Authors: Robert F. Meenan and John H. Mason (1980, 1991)
• Dutch Adaptation Authors: Robert P. Riemsma, Johannes J. Rasker, Gerjo A. M. Kok, H. J. Bernelot Moens (1994, 1996)
• Measurement Format: Standardized self-administered patient questionnaire (pen-and-paper or electronic interface)
• Target Population: Adults and older adults (≥ 18 years) diagnosed with chronic arthritis, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, or related musculoskeletal disorders
• Number of Items: 57 core health status items across 12 subscales
• Recall Period: Past month (preceding 30 days)
• Response Options: 5-point Likert scale (typically: 1 = All days / Always, 2 = Most days / Very often, 3 = Some days / Sometimes, 4 = Few days / Seldom, 5 = No days / Never; or frequency/severity tailored per section, reflecting experiences during the past month)
• Subscales (12):
  1. Mobility level (Items 1–5)
  2. Walking and bending (Items 6–10)
  3. Hand and finger function (Items 11–15)
  4. Arm function (Items 16–20)
  5. Self-care (Items 21–24)
  6. Household tasks (Items 25–28)
  7. Social activity (Items 29–33)
  8. Support from family and friends (Items 34–37)
  9. Arthritis pain (Items 38–42)
  10. Work (Items 43–47; completed only by patients active in workforce)
  11. Level of tension (Items 48–52)
  12. Mood (Items 53–57)
• Scoring and Normalization Rules:
  • Before summing, reverse-key individual items where high raw numerical scores represent better health, ensuring that for every item, a higher numeric score denotes greater limitation, symptom burden, or distress.
  • Sum the item responses within each subscale to obtain the raw subscale score.
  • Normalize each raw subscale score to a standardized 0–10 metric using the standard linear formula:
    
    Normalized Score = [(Raw Sum - Minimum Possible Sum) / (Maximum Possible Sum - Minimum Possible Sum)] × 10
  • Score Interpretation: A score of 0 indicates optimal health status, perfect functional capacity, or zero pain/distress. A score of 10 indicates extreme disability, maximum symptom severity, or severe psychological distress.
• Administration Time: Approximately 15 to 25 minutes for self-completion

Permissions & Fee and Test Year

The original Arthritis Impact Measurement Scales (AIMS) was released in 1980, followed by the expanded second-generation AIMS2 in 1991. The official Dutch translation, cross-cultural adaptation, and psychometric validation (Dutch-AIMS2) was published in 1994 and further refined in 1996 by Dr. Robert P. Riemsma and colleagues at the University of Twente. Subsequently, a short form (Dutch-AIMS2-SF) comprising 26 items was developed and validated in 2003.

The Dutch-AIMS2 is considered an academic, non-commercial assessment tool. It is widely accessible for academic, clinical, and non-funded scientific research purposes without royalty fees, provided appropriate scholarly attribution is cited. Researchers and healthcare institutions seeking to use the instrument in large-scale commercial pharmaceutical trials, or wishing to license specialized digital implementations, should contact the original authors, the copyright holders at Boston University, or the research consortium at the University of Twente / Dutch arthritis research registries.

References

• Meenan, R. F., Gertman, P. M., & Mason, J. H. (1980). Measuring health status in arthritis: The Arthritis Impact Measurement Scales. Arthritis & Rheumatism, 23(2), 146–152. https://doi.org/10.1002/art.1780230203
• Meenan, R. F., Mason, J. H., Anderson, J. J., Guccione, A. A., & Kazis, L. E. (1991). AIMS2: The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis & Rheumatism, 34(7), 795–802. https://doi.org/10.1002/art.1780340702
• Riemsma, R. P., Rasker, J. J., Taal, E., Griep, E. N., & Wouters, J. M. (1994). Psychometric properties of the Dutch Arthritis Impact Measurement Scales 2 (Dutch-AIMS2) in patients with rheumatoid arthritis. The Journal of Rheumatology, 21(11), 2028–2034.
• Riemsma, R. P., Taal, E., Rasker, J. J., & Bernelot Moens, H. J. (1996). Evaluation of the Dutch-AIMS2 in patients with rheumatoid arthritis and osteoarthritis: Dimensionality, reliability, and validity. Rheumatology International, 16(5), 183–190. https://doi.org/10.1007/BF01815124
• Riemsma, R. P., Taal, E., & Rasker, J. J. (2003). The Dutch version of the Arthritis Impact Measurement Scales 2 Short Form (Dutch-AIMS2-SF): Feasibility, reliability, and validity. The Journal of Rheumatology, 30(5), 978–983.
• Mason, J. H., Anderson, J. J., & Meenan, R. F. (1992). A standard approach to scoring the revised Arthritis Impact Measurement Scales (AIMS2). Arthritis & Rheumatism, 35(Suppl 9), S188.
• Fries, J. F., Spitz, P., Kraines, R. G., & Holman, H. R. (1980). Measurement of patient outcome in arthritis. Arthritis & Rheumatism, 23(2), 137–145. https://doi.org/10.1002/art.1780230202

Items of the Scale